Grants and Contributions:
Title:
COVID - 19: Therapeutic Development
Agreement Number:
953782
Agreement Value:
$82,060.00
Agreement Date:
Aug 1, 2020 - Jul 31, 2021
Description:
The project is to assist the firm develop a therapeutic applicable to the COVID-19 response by integrating internal documentation and resources with existing documentation and resources necessary to meet technical compliance requirements.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6C 1G8
Reference Number:
172-2020-2021-Q2-953782
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
803211184
Recipient Type:
For-profit organization
Recipient's Legal Name:
Algernon Pharmaceuticals Inc.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254